171 related articles for article (PubMed ID: 36536520)
1. Molecular Mediators and Regulators of Retinal Angiogenesis.
Vishwakarma S; Kaur I
Semin Ophthalmol; 2023 Feb; 38(2):124-133. PubMed ID: 36536520
[TBL] [Abstract][Full Text] [Related]
2. RhoB antibody alters retinal vascularization in models of murine retinopathy.
Almonte-Baldonado R; Bravo-Nuevo A; Gerald D; Benjamin LE; Prendergast GC; Laury-Kleintop LD
J Cell Biochem; 2019 Jun; 120(6):9381-9391. PubMed ID: 30536763
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
4. The role of the retinal pigment epithelium and Müller cells secretome in neovascular retinal pathologies.
Araújo RS; Santos DF; Silva GA
Biochimie; 2018 Dec; 155():104-108. PubMed ID: 29960032
[TBL] [Abstract][Full Text] [Related]
5. Small RNA Sequencing Reveals Transfer RNA-derived Small RNA Expression Profiles in Retinal Neovascularization.
Peng Y; Zou J; Wang JH; Zeng H; Tan W; Yoshida S; Zhang L; Li Y; Zhou Y
Int J Med Sci; 2020; 17(12):1713-1722. PubMed ID: 32714074
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.
Dai C; Webster KA; Bhatt A; Tian H; Su G; Li W
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062733
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-126 inhibits pathological retinal neovascularization via suppressing vascular endothelial growth factor expression in a rat model of retinopathy of prematurity.
Fan YY; Liu CH; Wu AL; Chen HC; Hsueh YJ; Chen KJ; Lai CC; Huang CY; Wu WC
Eur J Pharmacol; 2021 Jun; 900():174035. PubMed ID: 33727052
[TBL] [Abstract][Full Text] [Related]
8. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
Penn JS; Rajaratnam VS; Collier RJ; Clark AF
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):283-90. PubMed ID: 11133880
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Andreoli CM; Miller JW
Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed miRNAs in oxygen‑induced retinopathy newborn mouse models.
Wang Y; Wu S; Yang Y; Peng F; Li Q; Tian P; Xiang E; Liang H; Wang B; Zhou X; Huang H; Zhou X
Mol Med Rep; 2017 Jan; 15(1):146-152. PubMed ID: 27922698
[TBL] [Abstract][Full Text] [Related]
11. Complement involvement in neovascular ocular diseases.
Yanai R; Thanos A; Connor KM
Adv Exp Med Biol; 2012; 946():161-83. PubMed ID: 21948368
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy of prematurity: molecular pathology and therapeutic strategies.
Mechoulam H; Pierce EA
Am J Pharmacogenomics; 2003; 3(4):261-77. PubMed ID: 12930159
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and the HIF/VEGF axis in ocular neovascular diseases.
Plastino F; Pesce NA; André H
Acta Ophthalmol; 2021 Dec; 99(8):e1255-e1262. PubMed ID: 33729690
[TBL] [Abstract][Full Text] [Related]
14. Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.
Muniyandi A; Hartman GD; Song Y; Mijit M; Kelley MR; Corson TW
J Pharmacol Exp Ther; 2023 Jul; 386(1):15-25. PubMed ID: 37142441
[TBL] [Abstract][Full Text] [Related]
15. C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development.
Chen S; Sun Q; Sun D; Willette-Brown J; Anderson MJ; Gu Q; Lewandoski M; Hu Y; Zhu F; Wei F; Zhang J
Biomed Pharmacother; 2020 Dec; 132():110856. PubMed ID: 33125970
[TBL] [Abstract][Full Text] [Related]
16. Rice Bran and Vitamin B6 Suppress Pathological Neovascularization in a Murine Model of Age-Related Macular Degeneration as Novel HIF Inhibitors.
Ibuki M; Lee D; Shinojima A; Miwa Y; Tsubota K; Kurihara T
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255657
[TBL] [Abstract][Full Text] [Related]
17. Animal models of ocular angiogenesis: from development to pathologies.
Liu CH; Wang Z; Sun Y; Chen J
FASEB J; 2017 Nov; 31(11):4665-4681. PubMed ID: 28739642
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
Xia F; Sun JJ; Jiang YQ; Li CF
J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
[TBL] [Abstract][Full Text] [Related]
19. miR-106b suppresses pathological retinal angiogenesis.
Ménard C; Wilson AM; Dejda A; Miloudi K; Binet F; Crespo-Garcia S; Parinot C; Pilon F; Juneau R; Andriessen EM; Mawambo G; SanGiovanni JP; De Guire V; Sapieha P
Aging (Albany NY); 2020 Dec; 12(24):24836-24852. PubMed ID: 33361521
[TBL] [Abstract][Full Text] [Related]
20. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
Budd SJ; Thompson H; Hartnett ME
Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
